
Growth Hormone Research Bundle
- CJC-1295 (No DAC, 10mg) this product
- Ipamorelin (10mg)
- Sermorelin (10mg)
About this compound
CJC-1295 without Drug Affinity Complex (DAC), also called Modified GRF (1-29), is a 29-amino-acid synthetic analog of growth hormone releasing hormone (GHRH). Four amino acid substitutions protect the peptide from enzymatic cleavage and extend its half-life compared with native GHRH(1-29). The No DAC form lacks the albumin-binding group of the DAC version, so it has a shorter duration in experimental systems.
Research literature studies CJC-1295 (No DAC) in GHRH receptor signaling, growth hormone pulsatility in animal models, and the pharmacology of modified GHRH analogs, often in combination work with secretagogues such as ipamorelin.
Supplied as a lyophilized powder, 10mg per vial. Store sealed vials at -20°C, protected from light and moisture. For laboratory work the powder is reconstituted with bacteriostatic water or the buffer the protocol specifies; reconstituted material should be kept refrigerated and used within the stability window set by the research protocol.
For research use only. Not for human consumption, diagnostic, or therapeutic use.
Growth Hormone Peptides · 10mg
Earn 234 reward points on this vial with a free account. Sign in or join free
Modified GRF (1-29), synthetic GHRH analog without DAC. 10mg vial. Lyophilized powder. Research use only.
Independent third-party testing
Batch certification
LotEC-CJC-2026-044
The QR on every label opens all batch certificates; find the lot printed on your vial there, or type it here.
Published for every batch. No login required.
Discounts applied automatically at cart and checkout based on quantity. Mix and match bundles available across the catalog.
Subscribe and save
Choose how often CJC-1295 (No DAC, 10mg) ships and pay $42.29 per vial instead of $46.99. Each delivery is invoiced like a normal order. Change the plan, skip a delivery, pause or cancel any time from your account.
One-time purchase at $46.99 per vial. Pick a plan to save 10% on every delivery.
Plan pricing is per vial. Quantity discounts do not stack with a plan.

Product details
What it is, how it is verified and how it ships. Every batch is tested by an accredited U.S. lab, and the certificate of analysis is published for anyone to read.
CJC-1295 without Drug Affinity Complex (DAC), also called Modified GRF (1-29), is a 29-amino-acid synthetic analog of growth hormone releasing hormone (GHRH). Four amino acid substitutions protect the peptide from enzymatic cleavage and extend its half-life compared with native GHRH(1-29). The No DAC form lacks the albumin-binding group of the DAC version, so it has a shorter duration in experimental systems.
Research literature studies CJC-1295 (No DAC) in GHRH receptor signaling, growth hormone pulsatility in animal models, and the pharmacology of modified GHRH analogs, often in combination work with secretagogues such as ipamorelin.
Supplied as a lyophilized powder, 10mg per vial. Store sealed vials at -20°C, protected from light and moisture. For laboratory work the powder is reconstituted with bacteriostatic water or the buffer the protocol specifies; reconstituted material should be kept refrigerated and used within the stability window set by the research protocol.
For research use only. Not for human consumption, diagnostic, or therapeutic use.
Each batch is produced under strict quality controls with HPLC verification and full COA documentation. Supplied for research use only.
Dual verification on every batch: HPLC for purity, mass spectrometry for identity.
Every batch is tested by an accredited independent lab for identity, purity, sterility, and endotoxin levels. Every certificate is published below. No login required.
New lab reports appear within 24 hours of arriving from the lab.
Browse all lab resultsAll products are for research use only. Not for human consumption.
You must be at least 21 years of age to enter this site.